Treatment of schizophrenic patients - Recurrence rate falls with long-acting risperidone

被引：0
|
作者：
Oetzel, S
机构：
来源：
NERVENHEILKUNDE | 2004年 / 23卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：87 / 87
页数：1
相关论文
共 50 条
  • [1] Prolactin response to oral and long-acting forms of risperidone in schizophrenic patients
    Duval, Fabrice
    Chokmani, Nessim
    Mokrani, Marie-Claude
    He, Jun
    Duarte-Garcia, Frederico
    Macher, Jean-Paul
    BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 83S - 83S
  • [2] Prolactin response to oral and long-acting forms of risperidone in schizophrenic patients
    Duval, F.
    Chokmani, N.
    Mokrani, M. C.
    He, J.
    Macher, J. P.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S440 - S440
  • [3] Use of long-acting risperidone in the treatment of bipolar patients
    Savas, Haluk A.
    Yumru, Mehmet
    Ozen, Murat Eren
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2006, 26 (05) : 530 - 531
  • [4] Service utilisation of schizophrenic patients treated with long-acting injectable risperidone in Taiwan
    Chang, H.
    Su, K.
    McCropne, P.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S446 - S447
  • [5] EFFECTIVENESS OF LONG-ACTING INJECTABLE RISPERIDONE IN THE POST-ACUTE TREATMENT OF SCHIZOPHRENIC PATIENTS IN AMBULATORY CARE
    Hargarter, L.
    Diekamp, B.
    Ibach, B.
    Juckel, G.
    EUROPEAN PSYCHIATRY, 2010, 25
  • [6] Effectiveness of long-acting risperidone for patients with treatment refractory schizophrenia
    Kimura, H.
    Kanahara, N.
    Komasu, N.
    Ishige, M.
    Muneoka, K.
    Yoshimura, M.
    Yamanaka, H.
    Suzuki, T.
    Watanabe, H.
    Sekine, Y.
    Iyo, M.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 53 - 54
  • [7] Long-acting risperidone in the treatment of institutionalized mentally retarded patients
    Kouniakis, P.
    Tsirogianni, E.
    Baltatzi, M.
    Sidiropoulos, N.
    Hatzitolios, A.
    Giouzepas, J.
    Fokas, K.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S530 - S531
  • [8] Long-acting risperidone in the treatment of institutionalized mentally retarded patients
    Kouniakis, P.
    Tsirogianni, E.
    Baltatzi, M.
    Sidiropoulos, N.
    Hatzitolios, A.
    Giouzepas, I.
    Fokas, K.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S206 - S207
  • [9] COST-EFFECTIVENESS OF RISPERIDONE LONG-ACTING INJECTABLE VERSUS QUETIAPINE IN SCHIZOPHRENIC PATIENTS
    Elkis, H.
    Pereira, M.
    Kayo, M.
    Duchesne, I
    Alandete, J. C.
    VALUE IN HEALTH, 2009, 12 (07) : A521 - A521
  • [10] PSYCHOSOCIAL FUNCTIONING OF SCHIZOPHRENIC PATIENTS IN POST-ACUTE TREATMENT WITH LONG-ACTING INJECTABLE RISPERIDONE IN AMBULATORY CARE
    Juckel, G.
    Diekamp, B.
    Ibach, B.
    Hargarter, L.
    EUROPEAN PSYCHIATRY, 2010, 25
12345